ClinicalTrials.Veeva

Menu

Prognostic Factors for Acute Pulmonary Embolism in Critically Ill Patients

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Acute Pulmonary Embolism (PE)

Study type

Observational

Funder types

Other

Identifiers

NCT01839266
4-2013-0034

Details and patient eligibility

About

Acute pulmonary embolism (PE) is an important cause of in-hospital mortality and may be rapidly fatal if not diagnosed and treated. Despite recent advances in diagnostic and therapeutic modalities, it is still one of the important causes of hospital mortality. Previous several reports have described the variable outcome of patients with PE with reported mortality rate ranging from 8.1% (stable patients) to 25% (with cardiogenic shock) and 65% (post cardiopulmonary resuscitation). Nevertheless, there are no published studies from Korean hospitals that assessed the outcome of acute PE treated in the hospital with IV unfractionated heparin. We conducted this study to determine the outcome, risk factors, clinical characteristics and demographics of patients with acute PE and to identify possible demographic and clinical factors associated with prognosis.

Enrollment

200 patients

Sex

All

Ages

34+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients admitted to the Severance Hospital, Yonsei University Health System with primary diagnosis of PE between January 2008 and December 2012. (diagnosed by CT and treated in the hospital with IV unfractionated heparin)

Exclusion criteria

  1. diagnosis was prior to arrivalor
  2. anticoagulation was contraindicated
  3. diagnosis was not confirmed by CT

Trial design

200 participants in 1 patient group

acute PE survivor, acute PE nonsurvivor
Description:
acute PE survivor, acute PE nonsurvivor (in-hospital death)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems